Scientists make MS breakthrough

My Account
Logout

Create an Evening Standard Account

Use your social network

Save time by using your existing account to sign in to Evening Standard

We'll never share your information or post anything to your account without your permission

Welcome! Sign in here

Use your social network

Save time by using your existing account to sign in to Evening Standard

We'll never share your information or post anything to your account without your permission

Forgot your password ?

Registration

* indicates fields that are mandatory

Email *

Password *

Confirm Password *

First name *

Surname *

Postcode *

Country *

Mobile phone number

Username *

Gender *

Year of birth *

When you sign up...

You will have access to all our online competitions, discounted offers and can post comments on our site.

You will also receive The Weekender newsletter sent every Thursday - it’s full of fantastic offers and ideas for the weekend. You can update your email preferences in your account page when you log in.

Other newsletters and emails

Homes & Property Newsletter - Yes I want to receive the weekly email with all the latest news on property in the capital

Occasionally we would also like to send you relevant emails detailing specific offers either from ourselves or carefully selected partners. If you would prefer not to receive these then please tick the appropriate boxes below. We will never pass on your details.

I do not want to receive additional offers and information from the Evening Standard

I do not want to receive additional offers and information sent by Evening Standard on behalf of carefully selected partners

Terms and Conditions

* I have read, understood and agree to be bound by the terms and conditions of Evening Standard

Registration

Mail Sent for Registration Confirmation.

A confirmation email has been sent. Please activate your account by clicking on the activation link sent in your mail box.

A team at the University of Bristol carried out tests on mice and then on human brain tissue and found that the neuropeptide "galanin" was resistant to the MS-like disease, experimental autoimmune encephalomyelitis (EAE).

Professor David Wynick, who works on the function of galanin in the relief of neuropathic pain, initiated the project and worked with Professors David Wraith and Neil Scolding on the research.

Professor Wraith, who is working on a vaccine for the treatment of multiple sclerosis, said: "The results were really remarkable, rarely do you see such a dramatic effect as this.

"Mice with high levels of galanin just didn't develop any signs of disease.

"We have a lot more to do to figure out how this works but the results are extremely promising."

A spokeswoman for the university said that although the results are "very encouraging" there is still a large amount of work to be done before a drug can be developed and it could be at least 10 years before one is on the market.

She said the research team are now expected to seek the "substantial" funding needed to advance their findings.